{{Drugbox
| Watchedfields = changed
| verifiedrevid = 461098012
| IUPAC_name = (8''S'',9''S'',10''R'',13''S'',14''S'',17''R'')-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1''H''-cyclopenta[''a'']phenanthren-3-one
| image = Etonogestrel.svg
| width = 225px

<!--Clinical data-->
| tradename = Circlet, Implanon, Nexplanon, Nuvaring, others
| Drugs.com = {{drugs.com|MTM|etonogestrel}}
| MedlinePlus = a604032
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| legal_status = Rx-only
| routes_of_administration = Subdermal as slow-release implant

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = [[Liver]] ([[CYP3A4]])
| elimination_half-life = 25 hours
| excretion = [[Urine]] (major), [[feces]] (minor)

<!--Identifiers-->
| IUPHAR_ligand = 7590
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 54048-10-1
| ATC_prefix = G03
| ATC_suffix = AC08
| ATC_supplemental = 
| PubChem = 21729469
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00294
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5292944
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 304GTH6RNH
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04104
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50777
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1531

<!--Chemical data-->
| C=22 | H=28 | O=2
| molecular_weight = 324.457 g/mol
| SMILES = CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GCKFUYQCUCGESZ-BPIQYHPVSA-N
| synonyms = ORG-3236; 3-Ketodesogestrel; 11-Methylenelevonorgestrel;<ref name="Ryan1999">{{cite book|author=Kenneth J. Ryan|title=Kistner's Gynecology and Women's Health|url=https://books.google.com/books?id=i8xsAAAAMAAJ|year=1999|publisher=Mosby|isbn=978-0-323-00201-1|page=300}}</ref> 11-Methylene-17α-ethynyl-18-methyl-19-nortestosterone; 11-Methylene-17α-ethynyl-18-methylestr-4-en-17β-ol-3-one
}}

'''Etonogestrel''', sold under a number of brand names, is a [[progestin]] used in [[hormonal contraceptive]]s, most notably the [[etonogestrel contraceptive implant]] (Nexplanon, Implanon) and the [[contraceptive vaginal ring]] (NuvaRing, Circlet).<ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA1288|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=420}}</ref><ref name="LemkeWilliams2012">{{cite book|author1=Thomas L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA1409|date=24 January 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-60913-345-0|pages=1409–}}</ref> 

It was first introduced, as Implanon in [[Indonesia]], in 1998,<ref name="CarcioANP-BC2014">{{cite book|author1=Helen Carcio|author2=R. Mimi Secor|title=Advanced Health Assessment of Women, Third Edition: Clinical Skills and Procedures|url=https://books.google.com/books?id=P1uFBQAAQBAJ&pg=PA411|date=10 October 2014|publisher=Springer Publishing Company|isbn=978-0-8261-2308-4|pages=411–}}</ref><ref name="Mayeaux2012">{{cite book|author=E. J. Mayeaux|title=The Essential Guide to Primary Care Procedures|url=https://books.google.com/books?id=d-wNb7eyonMC&pg=PA589|date=28 March 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-4511-5286-9|pages=589–}}</ref> and was subsequently marketed in the [[United Kingdom]] shortly thereafter<ref name="GlasierWinikoff1999">{{cite book|author1=Anna Glasier|author2=Beverly Winikoff|title=Contraception|url=https://books.google.com/books?id=QYPiaMbHVCsC|date=December 1999|publisher=Health Press|isbn=978-1-899541-18-8|page=41}}</ref> and in the [[United States]] in 2006.<ref name="CarcioANP-BC2014" /><ref name="Mayeaux2012" /> Etonogestrel is less [[androgenic]] than [[levonorgestrel]] and [[norethisterone]],<ref name="Danby2015">{{cite book|author=F. William Danby|title=Acne: Causes and Practical Management|url=https://books.google.com/books?id=Z1yFBQAAQBAJ&pg=PA77|date=27 January 2015|publisher=John Wiley & Sons|isbn=978-1-118-23277-4|pages=77–}}</ref><ref name="Golan2008">{{cite book|author=David E. Golan|title=Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy|url=https://books.google.com/books?id=az8uSDkB0mgC&pg=PA521|year=2008|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-8355-2|pages=521–}}</ref> and it does not cause a decrease in [[sex hormone-binding globulin]] levels.<ref name="SperoffDarney2010">{{cite book|author1=Leon Speroff|author2=Philip D. Darney|title=A Clinical Guide for Contraception|url=https://books.google.com/books?id=f5XJtYkiJ0YC&pg=PT365|date=22 November 2010|publisher=Lippincott Williams & Wilkins|isbn=978-1-60831-610-6|pages=365–}}</ref> However, it is still associated with [[acne]] in up to 13% of patients when used as an implant, though this only accounts for 1% of premature removals.<ref name="LentzLobo2012">{{cite book|author1=Gretchen M Lentz|author2=Rogerio A. Lobo|author3=David M Gershenson|author4=Vern L. Katz|title=Comprehensive Gynecology|url=https://books.google.com/books?id=X5KT_w6Nye8C&pg=PA256|date=21 February 2012|publisher=Elsevier Health Sciences|isbn=0-323-09131-8|pages=256–}}</ref>

Etonogestrel is the [[active metabolite]] of the inactive prodrug [[desogestrel]], one of two third-generation progestins found in some [[epidemiological study|epidemiological studies]] of [[combined oral contraceptive pill]]s to be associated with a higher risk of [[venous thrombosis]] than combined oral contraceptive pills containing certain second-generation progestins. Because [[steroid hormone|hormone]]s are released continuously from NuvaRing, peak and total [[estrogen]] and progestin doses are significantly lower than with combined oral contraceptives, although it is not known whether this lowers the risk of [[blood clot]]s. It is effective within the first 8 hours of insertion.<ref name="LentzLobo2012"/>

==Chemistry==
{{See also|List of steroidal progestins}}

Etonogestrel, also known as 11-methylene-17α-ethynyl-18-methyl-19-nortestosterone or as 11-methylene-17α-ethynyl-18-methylestr-4-en-17β-ol-3-one, is a [[synthetic compound|synthetic]] [[estrane]] [[steroid]] and a [[chemical derivative|derivative]] of [[testosterone]].<ref name="IndexNominum2000" /><ref name="Drugs.com" /> It is more specifically a derivative of [[norethisterone]] (17α-ethynyl-19-nortestosterone) and is a member of the [[gonane]] (18-methylestrane) subgroup of the [[19-nortestosterone]] family of progestins.<ref name="BruckerKing2015">{{cite book|author1=Mary C. Brucker|author2=Tekoa L. King|title=Pharmacology for Women’s Health|url=https://books.google.com/books?id=AniUCgAAQBAJ&pg=PA368|date=8 September 2015|publisher=Jones & Bartlett Publishers|isbn=978-1-284-05748-5|pages=368–}}</ref><ref name="Shoupe2007">{{cite book|author=Donna Shoupe|title=The Handbook of Contraception: A Guide for Practical Management|url=https://books.google.com/books?id=sczb0Tk_2IwC&pg=PA16|date=7 November 2007|publisher=Springer Science & Business Media|isbn=978-1-59745-150-5|pages=16–}}</ref> Etonogestrel is the C3 [[ketone]] derivative of [[desogestrel]] and the C11 [[methylene group|methylene]] derivative of [[levonorgestrel]] and is also known as 3-ketodesogestrel and as 11-methylenelevonorgestrel.<ref name="Ryan1999" />

==Society and culture==

===Generic name===
''Etonogestrel'' is the [[generic term|generic name]] of the drug and its {{abbrlink|INN|International Nonproprietary Name}}, {{abbrlink|USAN|United States Adopted Name}}, and {{abbrlink|BAN|British Approved Name}}.<ref name="IndexNominum2000" /><ref name="Drugs.com">https://www.drugs.com/international/etonogestrel.html</ref>

===Brand names===
Etonogestrel is marketed under the brand names Circlet, Implanon, Nexplanon, and NuvaRing.<ref name="IndexNominum2000" /><ref name="Drugs.com">https://www.drugs.com/international/etonogestrel.html</ref>

==References==
{{Reflist|2}}

{{Progestogens and antiprogestogens}}
{{Progesterone receptor modulators}}
{{Androgen receptor modulators}}

[[Category:Alcohols]]
[[Category:Alkynes]]
[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Hormonal contraception]]
[[Category:Human drug metabolites]]
[[Category:Ketones]]
[[Category:Progestogens]]